(Total Views: 888)
Posted On: 01/26/2021 4:47:12 PM
Post# of 148900
So, with respect to your item #2
The long hauler trial is a phase 2. Sounds like the endpoints may be changing, but in the current protocol the longest endpoints are 56 days. Stands to reason this timeframe will remain.
If we start enrolling at the beginning of February, we should complete enrollment by lets say Mid March. Trial will complete Mid May. Results sometime beginning to middle of June.
This seems like an eternity, but given that COVID is likely to be endemic, and the sheer number of people worldwide that are having these symptoms, there will be a market much larger than we can even imagine.
My only concern with LH, is the cost of our medicine. I have not given the LH enough attention because of this concern. I think we should move full steam ahead with it, but I think its reasonable to think that we may end up being used on LH patients with the most pronounced symptoms and/or those that dont respond to less expensive treatments.
Quote:
2) The longhauler clinical trial did not yet start because the FDA had some comments on it that were addressed and no further comments were made so it should be starting in a few days, and because of huge interest in trial, it should complete within a month of starting.
The long hauler trial is a phase 2. Sounds like the endpoints may be changing, but in the current protocol the longest endpoints are 56 days. Stands to reason this timeframe will remain.
If we start enrolling at the beginning of February, we should complete enrollment by lets say Mid March. Trial will complete Mid May. Results sometime beginning to middle of June.
This seems like an eternity, but given that COVID is likely to be endemic, and the sheer number of people worldwide that are having these symptoms, there will be a market much larger than we can even imagine.
My only concern with LH, is the cost of our medicine. I have not given the LH enough attention because of this concern. I think we should move full steam ahead with it, but I think its reasonable to think that we may end up being used on LH patients with the most pronounced symptoms and/or those that dont respond to less expensive treatments.
(1)
(0)Scroll down for more posts ▼
